Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Entera Bio Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
Entera Bio has a total shareholder equity of $8.5M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $10.0M and $1.5M respectively.
Anahtar bilgiler
0%
Borç/özkaynak oranı
US$0
Borç
Faiz karşılama oranı | n/a |
Nakit | US$9.06m |
Eşitlik | US$8.53m |
Toplam yükümlülükler | US$1.50m |
Toplam varlıklar | US$10.04m |
Son finansal sağlık güncellemeleri
We're Keeping An Eye On Entera Bio's (NASDAQ:ENTX) Cash Burn Rate
Jul 12Here's Why We're Not Too Worried About Entera Bio's (NASDAQ:ENTX) Cash Burn Situation
Mar 23We're Keeping An Eye On Entera Bio's (NASDAQ:ENTX) Cash Burn Rate
May 31Will Entera Bio (NASDAQ:ENTX) Spend Its Cash Wisely?
Feb 15Recent updates
We're Keeping An Eye On Entera Bio's (NASDAQ:ENTX) Cash Burn Rate
Jul 12Here's Why We're Not Too Worried About Entera Bio's (NASDAQ:ENTX) Cash Burn Situation
Mar 23We're Keeping An Eye On Entera Bio's (NASDAQ:ENTX) Cash Burn Rate
May 31Will Entera Bio (NASDAQ:ENTX) Spend Its Cash Wisely?
Feb 15Is Entera Bio (NASDAQ:ENTX) In A Good Position To Deliver On Growth Plans?
Oct 13Entera Bio GAAP EPS of -$0.24 , revenue of $0.11M
Aug 11We Think Entera Bio (NASDAQ:ENTX) Needs To Drive Business Growth Carefully
Jun 10Companies Like Entera Bio (NASDAQ:ENTX) Are In A Position To Invest In Growth
Jan 21We're Interested To See How Entera Bio (NASDAQ:ENTX) Uses Its Cash Hoard To Grow
Oct 06Here's Why We're Not Too Worried About Entera Bio's (NASDAQ:ENTX) Cash Burn Situation
Jun 19Entera Bio secures European patent for oral PTH formulations
Jun 17We're Keeping An Eye On Entera Bio's (NASDAQ:ENTX) Cash Burn Rate
Mar 20Here's Why Entera Bio (NASDAQ:ENTX) Must Use Its Cash Wisely
Dec 05Entera Bio EPS misses by $0.22
Nov 19Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: ENTX's short term assets ($9.6M) exceed its short term liabilities ($1.3M).
Uzun Vadeli Yükümlülükler: ENTX's short term assets ($9.6M) exceed its long term liabilities ($209.0K).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: ENTX is debt free.
Borcun Azaltılması: ENTX had no debt 5 years ago.
Bilanço
Nakit Pist Analizi
Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.
İstikrarlı Nakit Pisti: ENTX has sufficient cash runway for more than a year based on its current free cash flow.
Tahmini Nakit Akışı: ENTX has sufficient cash runway for 1.1 years if free cash flow continues to grow at historical rates of 1.1% each year.